Answers are grounded in this paper and cite their sources.
Roxadustat is a viable option to treat anaemia in NDD CKD patients maintaining Hb levels for up to 104 weeks.
No takes yet. Share an insight, caveat, or question.
Barratt et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: